Pacira | PCRX - Umlaufvermögen

Aktienkurs
23.79
Täglich Wechseln
-0.03 -0.13%
Monatlich
4.21%
Jährlich
-3.14%
Q2 Prognose
23.14




Umlaufvermögen Veränderung Datum
Assertio Holdings USD 263.57M 53.36M 2025-09
Astellas Pharma JPY 1.44T 72.43B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cara Therapeutics USD 38.44M 4.69M 2025-09
Coherus Biosciences USD 206.71M 254.25M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
J&J USD 55.62B 1.01B 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12
Xoma USD 110.71M 5.78M 2025-09
Zoetis USD 6.77B 185M 2025-12